These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20674253)

  • 1. Two-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Operative morbidity and mortality in phase I and II trials.
    Kluger MD; Taub RN; Hesdorffer M; Jin Z; Chabot JA
    Eur J Surg Oncol; 2010 Oct; 36(10):997-1003. PubMed ID: 20674253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma: a controlled study.
    Baratti D; Kusamura S; Cabras AD; Deraco M
    Ann Surg Oncol; 2012 May; 19(5):1416-24. PubMed ID: 22302266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
    Baratti D; Vaira M; Kusamura S; D'Amico S; Balestra MR; Cioppa T; Mingrone E; De Simone M; Deraco M
    Eur J Surg Oncol; 2010 Nov; 36(11):1047-53. PubMed ID: 20832234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
    Deraco M; Nonaka D; Baratti D; Casali P; Rosai J; Younan R; Salvatore A; Cabras Ad AD; Kusamura S
    Ann Surg Oncol; 2006 Feb; 13(2):229-37. PubMed ID: 16444562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
    Sugarbaker PH
    Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Cabras AD; Dileo P; Laterza B; Deraco M
    Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Oliva GD; Laterza B; Deraco M
    Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
    Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
    Neragi-Miandoab S; Richards WG; Sugarbaker DJ
    Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.
    Vaira M; Cioppa T; D'Amico S; de Marco G; D'Alessandro M; Fiorentini G; De Simone M
    In Vivo; 2010; 24(1):79-84. PubMed ID: 20133981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesothelioma.
    Hesdorffer ME; Chabot JA; Keohan ML; Fountain K; Talbot S; Gabay M; Valentin C; Lee SM; Taub RN
    Am J Clin Oncol; 2008 Feb; 31(1):49-54. PubMed ID: 18376228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Cabras AD; Bertulli R; Hutanu I; Deraco M
    Eur J Cancer; 2013 Oct; 49(15):3140-8. PubMed ID: 23831335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma--a prospective study of 70 consecutive cases.
    Yan TD; Edwards G; Alderman R; Marquardt CE; Sugarbaker PH
    Ann Surg Oncol; 2007 Feb; 14(2):515-25. PubMed ID: 17031722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma.
    Yano H; Moran BJ; Cecil TD; Murphy EM
    Eur J Surg Oncol; 2009 Sep; 35(9):980-5. PubMed ID: 18977109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Deraco M; Baratti D; Hutanu I; Bertuli R; Kusamura S
    Ann Surg Oncol; 2013 Apr; 20(4):1093-100. PubMed ID: 23456386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion.
    Deraco M; Casali P; Inglese MG; Baratti D; Pennacchioli E; Bertulli R; Kusamura S
    J Surg Oncol; 2003 Jul; 83(3):147-53. PubMed ID: 12827682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma.
    Yan TD; Brun EA; Cerruto CA; Haveric N; Chang D; Sugarbaker PH
    Ann Surg Oncol; 2007 Jan; 14(1):41-9. PubMed ID: 17039392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant pleural mesothelioma: surgical management in 285 patients.
    Schipper PH; Nichols FC; Thomse KM; Deschamps C; Cassivi SD; Allen MS; Pairolero PC
    Ann Thorac Surg; 2008 Jan; 85(1):257-64; discussion 264. PubMed ID: 18154820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with peritoneal mesothelioma.
    Deraco M; De Simone M; Rossi CR; Cavaliere F; Difilippo F; Scuderi S; Pilatti P; Kusamura S
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):41-5. PubMed ID: 16767905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous extraperitoneal and intraperitoneal dissemination of appendix cancer.
    Carmignani CP; Sugarbaker PH
    Eur J Surg Oncol; 2004 Oct; 30(8):864-8. PubMed ID: 15336733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.